4.2 Article

Reannotation of translational start sites in the genome of Mycobacterium tuberculosis

Journal

TUBERCULOSIS
Volume 93, Issue 1, Pages 18-25

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2012.11.012

Keywords

Reannotation; Translational start sites; Orthologs; Actinobacteria

Funding

  1. NIH [P01AI095208]
  2. Robert A. Welch Foundation [A-0015]

Ask authors/readers for more resources

Identification and correction of incorrect ORF start sites is important for a variety of experimental and analytical purposes, ranging from cloning to inference of operon structure. The genome of the H37Rv reference strain of Mycobacterium tuberculosis ( Mtb) was originally annotated when it was first sequenced nearly 15 years ago. While this annotation has served the TB research community well as a standard of reference for over a decade, it has been demonstrated experimentally that the actual start sites for an estimated 5-10% of open reading frames differ from the annotation. In this paper, we present a comprehensive bioinformatic analysis of all 3989 ORFs ( open reading frames) in the M. tuberculosis H37Rv genome. Our method combines information from comparative analysis ( alignment to start sites of orthologs in other Actinobacteria), sequence conservation, protein likeness, putative ribosome binding sites, and other data to identify translational start sites. The features are combined in a linear model that is trained on dataset of known start sites verified by mass spectrometry, with a cross-validated accuracy of 94%. The method can be viewed as an augmentation of Hidden Markov Model-based tools such as Glimmer and GeneMark by incorporating more information than just the raw genomic sequence to decide which position is the legitimate translational start site for each ORF. Using this analysis, we identify 269 genes that most likely need to be re-annotated, and identify the best alterative translational start site for each. These revised ORF definitions could be used in the reannotation of the H37Rv genome, as well as to prioritize genes for experimental start-site validation. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Capturing Uncertainty by Modeling Local Transposon Insertion Frequencies Improves Discrimination of Essential Genes

Michael A. DeJesus, Thomas R. Ioerger

IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2015)

Article Microbiology

Trehalose-6-Phosphate-Mediated Toxicity Determines Essentiality of OtsB2 in Mycobacterium tuberculosis In Vitro and in Mice

Jan Korte, Marina Alber, Carolina M. Trujillo, Karl Syson, Hendrik Koliwer-Brandl, Rene Deenen, Karl Koehrer, Michael A. DeJesus, Travis Hartman, William R. Jacobs, Stephen Bornemann, Thomas R. Ioerger, Sabine Ehrt, Rainer Kalscheuer

PLOS PATHOGENS (2016)

Article Biochemical Research Methods

Normalization of transposon-mutant library sequencing datasets to improve identification of conditionally essential genes

Michael A. DeJesus, Thomas R. Ioerger

JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (2016)

Article Genetics & Heredity

Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction

Caitlin A. Orsini, Barry Setlow, Michael DeJesus, Stacy Galaviz, Kimberly Loesch, Thomas Ioerger, Deeann Wallis

MOLECULAR GENETICS & GENOMIC MEDICINE (2016)

Article Biochemistry & Molecular Biology

Statistical analysis of genetic interactions in Tn-Seq data

Michael A. DeJesus, Subhalaxmi Nambi, Clare M. Smith, Richard E. Baker, Christopher M. Sassetti, Thomas R. Ioerger

NUCLEIC ACIDS RESEARCH (2017)

Article Microbiology

Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis

Michael A. DeJesus, Elias R. Gerrick, Weizhen Xu, Sae Woong Park, Jarukit E. Long, Cara C. Boutte, Eric J. Rubin, Dirk Schnappinger, Sabine Ehrt, Sarah M. Fortune, Christopher M. Sassetti, Thomas R. Ioerger

Article Biochemical Research Methods

Statistical analysis of variability in TnSeq data across conditions using zero-inflated negative binomial regression

Siddharth Subramaniyam, Michael A. DeJesus, Anisha Zaveri, Clare M. Smith, Richard E. Baker, Sabine Ehrt, Dirk Schnappinger, Christopher M. Sassetti, Thomas R. Ioerger

BMC BIOINFORMATICS (2019)

Article Biochemistry & Molecular Biology

Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis

Barbara Bosch, Michael A. De Jesus, Nicholas C. Poulton, Wenzhu Zhang, Curtis A. Engelhart, Anisha Zaveri, Sophie Lavalette, Nadine Ruecker, Carolina Trujillo, Joshua B. Wallach, Shuqi Li, Sabine Ehrt, Brian T. Chait, Dirk Schnappinger, Jeremy M. Rock

Summary: The study suggests that traditional genetic approaches may not accurately identify high-value bacterial targets, while using CRISPR technology to modulate gene expression can help differentiate bacteria's vulnerability to gene inhibition, identifying both highly vulnerable genes and invulnerable essential genes.
Article Multidisciplinary Sciences

An improved statistical method to identify chemical-genetic interactions by exploiting concentration-dependence

Esha Dutta, Michael A. DeJesus, Nadine Ruecker, Anisha Zaveri, Eun-Ik Koh, Christopher M. Sassetti, Dirk Schnappinger, Thomas R. Ioerger

Summary: Chemical-genetics (C-G) experiments are used to identify interactions between inhibitory compounds and bacterial genes, potentially revealing drug targets or other functionally interacting genes and pathways. By constructing a library of hypomorphic strains, treating them with inhibitory compounds, and using high-throughput sequencing, changes in relative abundance of individual mutants can be quantified. A new statistical method called CGA-LMM is proposed for analyzing C-G data, capturing the dependence of gene abundance in the hypomorph library on increasing drug concentrations through slope coefficients. This method was applied to analyze interactions between Mycobacterium tuberculosis hypomorph libraries and antibiotics, successfully identifying known target genes or expected interactions for the majority of drugs tested.

PLOS ONE (2021)

Article Microbiology

CRISPR Interference Reveals That All-Trans-Retinoic Acid Promotes Macrophage Control of Mycobacterium tuberculosis by Limiting Bacterial Access to Cholesterol and Propionyl Coenzyme A

Gregory H. Babunovic, Michael A. DeJesus, Barbara Bosch, Michael R. Chase, Thibault Barbier, Amy K. Dickey, Bryan D. Bryson, Jeremy M. Rock, Sarah M. Fortune

Summary: The study found that the application of all-trans-retinoic acid (ATRA) can enhance the control of Mycobacterium tuberculosis (Mtb) by human macrophages, which is achieved by altering macrophage cholesterol trafficking and lipid metabolism. In addition, CRISPR interference screening was used to identify specific genes required for Mtb survival in ATRA-activated macrophages.
Article Microbiology

CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis

Shuqi Li, Nicholas C. Poulton, Jesseon S. Chang, Zachary A. Azadian, Michael A. DeJesus, Nadine Ruecker, Matthew D. Zimmerman, Kathryn A. Eckartt, Barbara Bosch, Curtis A. Engelhart, Daniel F. Sullivan, Martin Gengenbacher, Veronique A. Dartois, Dirk Schnappinger, Jeremy M. Rock

Summary: This study utilized a CRISPR interference chemical-genetics platform to uncover various drug resistant mechanisms in Mycobacterium tuberculosis (Mtb) and identified a potential new drug for treating tuberculosis.

NATURE MICROBIOLOGY (2022)

Article Microbiology

Mutations in rv0678 Confer Low-Level Resistance to Benzothiazinone DprE1 Inhibitors in Mycobacterium tuberculosis

Nicholas C. Poulton, Zachary A. Azadian, Michael A. DeJesus, Jeremy M. Rock

Summary: Tuberculosis is a fatal bacterial infection, causing 1.5 million deaths globally each year. Drug-resistant strains of Mycobacterium tuberculosis (Mtb) have emerged, leading to efforts in developing novel drugs. The arabinogalactan biosynthetic enzyme DprE1 in Mtb is a promising drug target, with over a dozen inhibitory compounds identified. Among them, BTZ043 and PBTZ169 have shown promise and are in clinical trials. A study using CRISPRi chemical-genetic screen with PBTZ169 identified rv0678 as a negative regulator of the mmpS5/L5 drug efflux pump, which confers resistance to PBTZ169. Mutations in rv0678 are associated with resistance to another drug, bedaquiline. These results highlight the importance of monitoring for rv0678 mutations in ongoing clinical trials of BTZ043 and PBTZ169.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Microbiology

Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis

Weizhen Xu, Michael A. DeJesus, Nadine Rucker, Curtis A. Engelhart, Meredith G. Wright, Claire Healy, Kan Lin, Ruojun Wang, Sae Woong Park, Thomas R. Ioerger, Dirk Schnappinger, Sabine Ehrt

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Article Microbiology

CRISPR Interference Reveals That All-Trans-Retinoic Acid Promotes Macrophage Control of Mycobacterium tuberculosis by Limiting Bacterial Access to Cholesterol and Propionyl Coenzyme A

Gregory H. Babunovic, Michael A. DeJesus, Barbara Bosch, Michael R. Chase, Thibault Barbier, Amy K. Dickey, Bryan D. Bryson, Jeremy M. Rock, Sarah M. Fortune

Summary: This study identifies that the treatment with ATRA can enhance the control ability of macrophages against Mycobacterium tuberculosis (Mtb) by affecting bacterial clearance through changes in macrophage cholesterol metabolism, and conducts the first Mtb CRISPR interference screen in the infection model, revealing certain Mtb genes specifically required to survive in ATRA-activated macrophages.
Article Multidisciplinary Sciences

An improved statistical method to identify chemical-genetic interactions by exploiting concentration-dependence

Esha Dutta, Michael A. DeJesus, Nadine Ruecker, Anisha Zaveri, Eun-Ik Koh, Christopher M. Sassetti, Dirk Schnappinger, Thomas R. Ioerger

Summary: Chemical-genetics experiments can identify interactions between inhibitory compounds and bacterial genes, revealing drug targets or functionally interacting genes. By using Linear Mixed Models, a statistical method known as CGA-LMM can analyze C-G data and detect candidate gene interactions based on their abundance changes with increasing drug concentrations.

PLOS ONE (2021)

No Data Available